Exact Sciences Corporation

Exact Sciences Corp.
TypeSubsidiary
Nasdaq: EXAS
IndustryMolecular diagnostics
Founded1995 (1995) in Marlborough, Massachusetts
Founders
  • Stanley Lapidus
  • Anthony P. Shuber
HeadquartersMadison, Wisconsin, U.S.
Key people
ProductsCologuard, Oncotype DX, Oncotype MAP
RevenueIncrease US$2.50 billion (2023)
Increase US$−215 million (2023)
Increase US$−204 million (2023)
Total assetsIncrease US$6.47 billion (2023)
Total equityIncrease US$3.15 billion (2023)
Number of employees
6,500 (Dec 2023)
ParentAbbott Laboratories
Subsidiaries
Subsidiary List
  • Biomatrica
  • Exact Sciences Development
  • Exact Sciences Innovation
  • Exact Sciences International
  • Exact Sciences Laboratories
  • Exact Sciences Thrive
  • Genomic Health
  • Paradigm Diagnostics
  • Prevention Genetics
Websiteexactsciences.com
Footnotes

Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.

In November 2025, Abbott Laboratories announced an agreement to acquire Exact Sciences in a deal worth roughly $21 billion.